🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of Volunteer-Engaged Lifestyle Optimisation Via ICOPE on Sarcopenia in Older Adults (VELO-S)

RecruitingNAAges 60 Years - anyAllThe University of Hong Kong
NCT07345832 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Sarcopenia prevention and management are highly prioritised goals in the Healthy Ageing agenda. The study aims to: 1) evaluate the effects of the digital-enhanced, volunteer-engaged collaborative care pathway to improve sarcopenia, reduce fall risk, and increase health-related quality of life (HRQL) among community-dwelling older adults with risk of, or diagnosed with, sarcopenia; 2) evaluate whether the volunteers who received health coach capacity training and supported the intervention experienced health benefits across time; 3) explore the engagement experiences and perceived effects of elderly participants with sarcopenia during the program; 4) evaluate the intervention implementation process and effects from the perspectives of social care workers.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. aged 60 or above 2. Pseudo-Sarcopenia as indicated by a score on SARC-CaIF ≥11, OR sarcopenia according relative BIA-based appendicular skeletal mass/ height (Men: \<7 kg/m2; women: \<5.7 kg/m2), OR handgrip strength on dominant hand (male \<28 kg, female \<18 kg) (Chen et al., 2025) 3. the ability to use a smartphone, electronic tablet, or computer 4. consent to participate Exclusion Criteria: 1. having medical conditions contradictory to physical activity including unstable cardiovascular and orthopaedic conditions 2. engaging in other structured health promotion program involving physical activity and nutritional enhancement
💊

What it tests

  • Volunteer-Engaged Lifestyle Optimisation via ICOPE for Sarcopenia program (VELO-S)
  • Attention control
📍

Where

1 site
The University of Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy